|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
SCIDIR_on1298513580 |
| 003 |
OCoLC |
| 005 |
20231120010633.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
220220t20222022ne a ob 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d OPELS
|d OCLCO
|d UKMGB
|d OCLCF
|d UKAHL
|d INM
|d SFB
|d OCLCQ
|d N$T
|d CNCNC
|d OCLCO
|
| 015 |
|
|
|a GBC1I6259
|2 bnb
|
| 016 |
7 |
|
|a 020387523
|2 Uk
|
| 019 |
|
|
|a 1298558577
|a 1298656890
|a 1298677089
|
| 020 |
|
|
|a 9780128206706
|q (electronic bk.)
|
| 020 |
|
|
|a 0128206705
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128206690
|q (print)
|
| 020 |
|
|
|z 0128206691
|q (print)
|
| 035 |
|
|
|a (OCoLC)1298513580
|z (OCoLC)1298558577
|z (OCoLC)1298656890
|z (OCoLC)1298677089
|
| 050 |
|
4 |
|a RC422.D52
|
| 060 |
|
4 |
|a WK 835
|
| 082 |
0 |
4 |
|a 616.4/62
|2 23
|
| 245 |
0 |
0 |
|a Diabetic neuropathy /
|c edited by Mitra Tavakoli.
|
| 264 |
|
1 |
|a Amsterdam :
|b Elsevier,
|c [2022]
|
| 264 |
|
4 |
|c �2022
|
| 300 |
|
|
|a 1 online resource :
|b illustrations (chiefly color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 336 |
|
|
|a still image
|b sti
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 588 |
0 |
|
|a Online resource; title from table of contents page (Elsevier ClinicalKey, viewed May 3, 2022).
|
| 505 |
0 |
|
|a 1. Classification, risk factors, and symptoms of diabetic neuropathy; 2. Pathologic basis of diabetic neuropathy in humans; 3. Electrodiagnostic evaluation in diabetic neuropathy; 4. Advances in screening, early diagnosis and accurate staging of diabetic neuropathy; 5. Skin Biopsy and Diabetic Neuropathy; 6. Central Nervous System Involvement in Painful Diabetic Neuropathy; 7. Spinal Cord Involvement in Diabetic Neuropathy and Neuropathic Pain; 8. The conundrum and enigma of painful and painless neuropathy; 9. Motor Dysfunction in Diabetes; 10. Diabetic Autonomic Neuropathy: Measurement and Management, Part 1: Measurement: 11. Diabetic neuropathy in children and youth; 12. Treatment-Induced Painful Diabetic Neuropathy; 13. Costs of Diabetic Neuropathy and Diabetic Foot;14. Diabetic Foot; 15. Management of Diabetic Foot Disease; 16. Strategies for the Prevention or Reversal of Neuropathy; 17. Treatment of diabetic peripheral neuropathy: technologies, exercise and alternative treatments; 18. Treatment of Diabetic Polyneuropathy;19. Diabetic Autonomic Neuropathy: Measurement and Management, Part II: Management 20. Translating a Treatment for Diabetic Peripheral Neuropathy from Rodents to Humans: can a case be made for Fish Oil and Salsalate? 21. Bedside Clinical Features and Translational Snapshots of Diabetic
|
| 650 |
|
0 |
|a Diabetic neuropathies.
|
| 650 |
|
2 |
|a Diabetic Neuropathies
|0 (DNLM)D003929
|
| 650 |
|
6 |
|a Neuropathies diab�etiques.
|0 (CaQQLa)201-0010251
|
| 650 |
|
7 |
|a Diabetic neuropathies
|2 fast
|0 (OCoLC)fst00892230
|
| 700 |
1 |
|
|a Tavakoli, Mitra,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|z 9780128206706
|
| 776 |
0 |
8 |
|i Print version:
|t DIABETIC NEUROPATHY.
|d [S.l.] : ELSEVIER, 2022
|z 0128206691
|w (OCoLC)1263022460
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128206690
|z Texto completo
|
